Phase II Trial of Docetaxel and Cisplatin Neoadjuvant Chemotherapy Followed by Intensity Modulated Radiation Therapy With Concurrent Cisplatin in Advanced Nasopharyngeal Carcinoma

Neoadjuvant Chemotherapy ◽

Phase Ii ◽

Phase Ii Trial ◽

Surgical and Pathologic Outcomes in Patients on a Phase II Trial of Neoadjuvant Chemotherapy and Hypofractionated Image-Guided Intensity Modulated Radiation Therapy (HIGRT) in Resectable and Borderline Resectable Pancreatic Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2018.07.056 ◽

2018 ◽

Vol 102 (3) ◽

pp. S180

Author(s):

S.J. Stephens ◽

B. Czito ◽

X. Zhang ◽

E. Duffy ◽

M. Malicki ◽

...

Keyword(s):

Pancreatic Cancer ◽

Radiation Therapy ◽

Neoadjuvant Chemotherapy ◽

Phase Ii ◽

Phase Ii Trial ◽

Resectable Pancreatic Cancer ◽

Borderline Resectable ◽

Image Guided ◽

37 A phase II trial of intensity modulated radiation therapy for nasopharyngeal carcinoma

Radiotherapy and Oncology ◽

10.1016/s0167-8140(04)80539-5 ◽

2004 ◽

Vol 72 ◽

pp. S12

Keyword(s):

Radiation Therapy ◽

Phase Ii ◽

Phase Ii Trial ◽

A randomized phase II/III study of adverse events between sequential (SEQ) versus simultaneous integrated boost (SIB) intensity modulated radiation therapy (IMRT) in nasopharyngeal carcinoma; preliminary result on acute adverse events

Radiation Oncology ◽

10.1186/s13014-015-0472-y ◽

2015 ◽

Vol 10 (1) ◽

Cited By ~ 16

Author(s):

Anussara P. Songthong ◽

Danita Kannarunimit ◽

Chakkapong Chakkabat ◽

Chawalit Lertbutsayanukul

Keyword(s):

Radiation Therapy ◽

Adverse Events ◽

Phase Ii ◽

Simultaneous Integrated Boost ◽

Intensity Modulated ◽

Randomized Phase Ii ◽

Integrated Boost

Four-Week Neoadjuvant Intensity-Modulated Radiation Therapy With Concurrent Capecitabine and Oxaliplatin in Locally Advanced Rectal Cancer Patients: A Validation Phase II Trial

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2011.06.2008 ◽

2012 ◽

Vol 83 (2) ◽

pp. 587-593 ◽

Cited By ~ 25

Author(s):

Leire Arbea ◽

Rafael Martínez-Monge ◽

Juan A. Díaz-González ◽

Marta Moreno ◽

Javier Rodríguez ◽

...

Keyword(s):

Rectal Cancer ◽

Radiation Therapy ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Advanced Rectal Cancer ◽

Locally Advanced Rectal Cancer ◽

Intensity-modulated radiation therapy with simultaneous integrated boost technique following neoadjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma

Head & Neck ◽

10.1002/hed.21076 ◽

2009 ◽

Vol 31 (9) ◽

pp. 1121-1128 ◽

Cited By ~ 26

Author(s):

Kyubo Kim ◽

Hong-Gyun Wu ◽

Hak Jae Kim ◽

Myung-Whun Sung ◽

Kwang Hyun Kim ◽

...

Keyword(s):

Radiation Therapy ◽

Neoadjuvant Chemotherapy ◽

Simultaneous Integrated Boost ◽

Intensity Modulated ◽

Integrated Boost

Phase II trial of first-line chemoradiotherapy with intensity-modulated radiation therapy followed by chemotherapy for synchronous unresectable distant metastases rectal adenocarcinoma

Radiation Oncology ◽

10.1186/1748-717x-8-10 ◽

2013 ◽

Vol 8 (1) ◽

pp. 10 ◽

Cited By ~ 5

Author(s):

Ji Zhu ◽

Peng Lian ◽

Fangqi Liu ◽

Ye Xu ◽

Junyan Xu ◽

...

Keyword(s):

Radiation Therapy ◽

Phase Ii ◽

Phase Ii Trial ◽

Rectal Adenocarcinoma ◽

Distant Metastases ◽

First Line ◽

Hypofractionated radiotherapy to the prostate bed with intensity modulated radiation therapy (IMRT): a phase II trial

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2020.12.020 ◽

2020 ◽

Author(s):

Elton Trigo Teixeira Leite ◽

Clarissa Cerchi Angotti Ramos ◽

Victor Augusto Bertotti Ribeiro ◽

Bernardo Peres Salvajoli ◽

William Carlos Nahas ◽

...

Keyword(s):

Radiation Therapy ◽

Phase Ii ◽

Phase Ii Trial ◽

Hypofractionated Radiotherapy ◽

Intensity Modulated ◽

Prostate Bed

Phase II Trial of Hyperfractionated Intensity-Modulated Radiation Therapy and Concurrent Weekly Cisplatin for Stage III and IVa Head-and-Neck Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2009.12.046 ◽

2011 ◽

Vol 79 (4) ◽

pp. 1081-1088 ◽

Cited By ~ 21

Author(s):

Patrick D. Maguire ◽

Michael Papagikos ◽

Sue Hamann ◽

Charles Neal ◽

Martin Meyerson ◽

...

Keyword(s):

Radiation Therapy ◽

Head And Neck Cancer ◽

Head And Neck ◽

Phase Ii ◽

Neck Cancer ◽

Phase Ii Trial ◽

Stage Iii ◽

Intensity Modulated ◽

Weekly Cisplatin

Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy

Radiation Oncology ◽

10.1186/1748-717x-7-82 ◽

2012 ◽

Vol 7 (1) ◽

Cited By ~ 33

Author(s):

Jeffrey Vainshtein ◽

Eyad Abu-Isa ◽

Karin B Olson ◽

Michael E Ray ◽

Howard M Sandler ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

Phase Ii ◽

Phase Ii Trial ◽

Focal Therapy ◽

Intensity Modulated ◽

Randomized Phase Ii ◽

Risk Prostate Cancer ◽

Low Risk Prostate Cancer

Phase II trial of bevacizumab + cetuximab + cisplatin with concurrent intensity-modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinoma

Head & Neck ◽

10.1002/hed.24041 ◽

2015 ◽

Vol 38 (S1) ◽

pp. E566-E570 ◽

Cited By ~ 20

Author(s):

Matthew G. Fury ◽

Han Xiao ◽

Eric J. Sherman ◽

Shrujal Baxi ◽

Stephanie Smith-Marrone ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Radiation Therapy ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Neck Squamous Cell Carcinoma ◽